EGFR and lung carcinoma: Therapeutic effect of our synthetic fc-rPEI-Cdots/pooled siRNA (cyclin B1 plus EGFR) and fc-rPEI-Cdots/single siRNA (cyclin B1) nanoagents was examined by measuring viability of lung cancer cells after treatment.